Foundation of Johnson & Johnson
Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey.
1886
1888
First Aid Kits Introduction
Johnson & Johnson introduced the first commercial first aid kits, which were initially designed to help railroad workers.
1894
Launch of Johnson's Baby Powder
Johnson & Johnson launched Johnson's Baby Powder, which became one of the company's most iconic products.
1921
Introduction of Band-Aid Brand Adhesive Bandages
Johnson & Johnson introduced Band-Aid brand adhesive bandages, revolutionizing wound care for consumers.
1959
Acquisition of McNeil Laboratories
Johnson & Johnson acquired McNeil Laboratories, which led to the introduction of Tylenol, a widely used pain reliever.
1961
Acquisition of Janssen Pharmaceutica
Johnson & Johnson acquired Janssen Pharmaceutica, expanding its pharmaceutical capabilities and product offerings.
1976
Introduction of Disposable Contact Lenses
Johnson & Johnson's subsidiary, Vistakon, introduced the first disposable soft contact lenses, Acuvue.
1987
Acquisition of LifeScan
Johnson & Johnson acquired LifeScan, a company specializing in blood glucose monitoring systems for diabetes management.
1998
Acquisition of DePuy, Inc.
Johnson & Johnson acquired DePuy, Inc., a leading orthopedic products manufacturer, expanding its medical devices segment.
2006
Acquisition of Pfizer Consumer Healthcare
Johnson & Johnson acquired Pfizer Consumer Healthcare, adding popular brands like Listerine and Nicorette to its portfolio.
2012
Acquisition of Synthes, Inc.
Johnson & Johnson completed the acquisition of Synthes, Inc., a global manufacturer of orthopedic devices, for $19.7 billion.
2017
Acquisition of Actelion Pharmaceuticals
Johnson & Johnson acquired Actelion Pharmaceuticals, a leader in pulmonary arterial hypertension treatments, for $30 billion.
2019
Launch of J&J Innovation Centers
Johnson & Johnson launched its Innovation Centers to foster collaboration and accelerate the development of new healthcare solutions.
2020
COVID-19 Vaccine Development
Johnson & Johnson began the development of its single-dose COVID-19 vaccine, which received Emergency Use Authorization from the FDA in 2021.
2023
Spin-off of Consumer Health Business
Johnson & Johnson announced the spin-off of its consumer health business into a new publicly traded company, Kenvue, to focus on pharmaceutical and medical device segments.
